XML 52 R199.htm IDEA: XBRL DOCUMENT v3.20.1
Appendix II - Operating Segments (Details) - EUR (€)
€ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Segment Reporting      
Revenues from external customers € 5,098,691 € 4,486,724 € 4,318,073
Profit /(loss) 1,131,365 994,124 1,003,343
Finance result (274,724) (257,244) (287,734)
Share of profit / (losses) (39,538) (11,038) (19,887)
Income tax expense (168,459) (131,436) (34,408)
Consolidated profit for the year 648,644 594,406 661,314
Investments in equity-accounted investees 114,473 226,905 219,009
Assets 15,542,611 12,477,046 10,920,264
Liabilities 8,696,843 7,780,442 7,286,299
Other information:      
Amortisation and depreciation 302,455 228,609 215,490
Additions for the year of property, plant & equipment, intangible assets and rights of use 1,175,072 316,677 340,473
Operating Segments      
Segment Reporting      
Revenues from external customers 5,098,691 4,486,724 4,318,073
Total operating income 5,098,691 4,486,724 4,318,073
Profit /(loss) 1,300,801 1,156,653 1,237,470
Segment assets 12,638,606 10,847,654 9,554,477
Liabilities 1,938,462 1,068,786 656,598
Other information:      
Amortisation and depreciation 282,807 219,339 206,966
Expenses that do not require cash payments 20,755 145,322 2,112
Additions for the year of property, plant & equipment, intangible assets and rights of use 1,101,528 296,882 329,205
Unallocated      
Segment Reporting      
Profit /(loss) (169,436) (162,529) (234,127)
Assets 2,789,532 1,402,487 1,146,778
Liabilities 6,758,381 6,711,656 6,629,701
Other information:      
Amortisation and depreciation 19,648 9,270 8,524
Expenses that do not require cash payments 2,416 1,339 (58,752)
Additions for the year of property, plant & equipment, intangible assets and rights of use 73,544 19,795 11,268
Intersegments      
Segment Reporting      
Revenues from external customers (52,176) (41,154) (34,784)
Total operating income (52,176) (41,154) (34,784)
Profit /(loss) (3,094) (5,764) (12,305)
Segment assets (32,892) (29,281) (22,196)
Bioscience      
Segment Reporting      
Share of profit / (losses)   2,839 (10,434)
Investments in equity-accounted investees 10,368 99,547 83,905
Bioscience | Operating Segments      
Segment Reporting      
Revenues from external customers 3,993,462 3,516,704 3,429,785
Total operating income 3,993,462 3,516,704 3,429,785
Profit /(loss) 1,079,216 902,402 985,495
Segment assets 8,416,922 6,928,220 6,007,153
Liabilities 1,371,352 764,377 423,415
Other information:      
Amortisation and depreciation 196,335 156,893 157,478
Expenses that do not require cash payments 43,524 172,648 7,049
Additions for the year of property, plant & equipment, intangible assets and rights of use 868,103 220,531 227,635
Hospital      
Segment Reporting      
Share of profit / (losses)     2,112
Hospital | Operating Segments      
Segment Reporting      
Revenues from external customers 134,441 119,454 105,649
Total operating income 134,441 119,454 105,649
Profit /(loss) (8,674) (12,587) (9,766)
Segment assets 274,250 250,543 145,477
Liabilities 53,441 32,767 13,560
Other information:      
Amortisation and depreciation 11,686 10,819 6,436
Expenses that do not require cash payments (289) 297 (514)
Additions for the year of property, plant & equipment, intangible assets and rights of use 62,298 15,354 10,429
Diagnostic      
Segment Reporting      
Share of profit / (losses) (19,794) (10,975) (9,335)
Investments in equity-accounted investees   19,256 29,322
Diagnostic | Operating Segments      
Segment Reporting      
Revenues from external customers 733,604 702,265 732,369
Total operating income 733,604 702,265 732,369
Profit /(loss) 215,828 215,990 248,080
Segment assets 3,676,011 3,526,136 3,356,185
Liabilities 351,799 230,517 192,720
Other information:      
Amortisation and depreciation 52,224 44,030 40,815
Expenses that do not require cash payments (22,873) (27,651) (4,423)
Additions for the year of property, plant & equipment, intangible assets and rights of use 103,911 58,064 70,032
Bio supplies      
Segment Reporting      
Share of profit / (losses)   3,039 1,830
Investments in equity-accounted investees 49,922 47,742 44,220
Bio supplies | Operating Segments      
Segment Reporting      
Revenues from external customers 266,540 167,004 66,791
Total operating income 266,540 167,004 66,791
Profit /(loss) 16,246 36,824 35,598
Segment assets 226,814 117,673 7,409
Liabilities 126,289 6,427  
Other information:      
Amortisation and depreciation 20,415 5,656  
Expenses that do not require cash payments 393 28  
Additions for the year of property, plant & equipment, intangible assets and rights of use 65,448 2,050 198
Others      
Segment Reporting      
Share of profit / (losses) (19,744) (5,941) (4,060)
Investments in equity-accounted investees 54,183 60,360 61,562
Others | Operating Segments      
Segment Reporting      
Revenues from external customers 22,820 22,451 18,263
Total operating income 22,820 22,451 18,263
Profit /(loss) 1,279 19,788 (9,632)
Segment assets 77,501 54,363 60,449
Liabilities 35,581 34,698 26,903
Other information:      
Amortisation and depreciation 2,147 1,941 2,237
Additions for the year of property, plant & equipment, intangible assets and rights of use € 1,768 € 883 € 20,911